Analyst firms · H.C. Wainwright · VTYX
H.C. Wainwright VTYX price target and rating history
Ventyx Biosciences Inc. (VTYX) · Health Care
H.C. Wainwright rates Ventyx Biosciences Inc. (VTYX) Buy with a $18 price target, as of its latest action on Nov 5, 2025. It has published 3 rating actions on VTYX since September 2022, including 1 upgrade and 1 downgrade.
- Current rating
- Buy
- Price target
- $18
- Median target, all firms
- Too few
- Actions on VTYX
- 3
H.C. Wainwright price target on VTYX
Every H.C. Wainwright rating on VTYX
- Nov 5, 2025
- Nov 7, 2023
- Sep 1, 2022
Questions about H.C. Wainwright and VTYX
- What is H.C. Wainwright's price target for VTYX?
- H.C. Wainwright's latest stated price target for Ventyx Biosciences Inc. (VTYX) is $18, from its action on Nov 5, 2025.
- What is H.C. Wainwright's rating on VTYX?
- H.C. Wainwright rates VTYX Buy, a bullish rating, as of Nov 5, 2025.
- When did H.C. Wainwright last change its view on VTYX?
- On Nov 5, 2025, H.C. Wainwright upgrades to Buy from Neutral, price target $18.
More VTYX rating histories
All H.C. Wainwright ratingsVTYX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.